# EDGAR Filing Document

**Accession Number:** 0000070318
**File Stem:** 0000070318-26-000028
**Filing Date:** 2026-5
**Character Count:** 6378
**Document Hash:** 7bef65afa0f02446e1a9f6818b2f2236
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000070318-26-000028.hdr.sgml**: 20260529

**ACCESSION NUMBER**: 0000070318-26-000028

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260527

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260529

**DATE AS OF CHANGE**: 20260529

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TENET HEALTHCARE CORP
- **CENTRAL INDEX KEY:** 0000070318
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 952557091
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07293
- **FILM NUMBER:** 261044288

**BUSINESS ADDRESS:**
- **STREET 1:** 14201 DALLAS PARKWAY
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75254
- **BUSINESS PHONE:** 469-893-2200

**MAIL ADDRESS:**
- **STREET 1:** 14201 DALLAS PARKWAY
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75254

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NATIONAL MEDICAL ENTERPRISES INC /NV/
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? thc-20260527

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_______________

**FORM 8-K** 

_______________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of**

**the Securities Exchange Act of 1934**

**Date of Report: May 27, 2026** 

**(Date of earliest event reported)**

_______________

**TENET HEALTHCARE CORPORATION**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Nevada** | **1-7293** | **95-2557091** |
| **(State of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification Number)** |

---

_______________

**14201 Dallas Parkway** 

**Dallas, TX 75254** 

**(Address of principal executive offices, including zip code)**

**(469) 893-2200** 

**(Registrant's telephone number, including area code)**

_______________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange <br>on which registered** |
| Common stock, $0.05 par value | THC | NYSE |
| 6.875% Senior Notes due 2031 | THC31 | NYSE |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07.** | **Submission of Matters to a Vote of Security Holders.** |

---

The 2026 Annual Meeting of Shareholders (the "Annual Meeting") of Tenet Healthcare Corporation (the "Company") was held on May 27, 2026. Below are the final voting results from the meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;The Company's shareholders elected the following directors to serve on the Company's Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director's earlier resignation or removal:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **FOR** | **AGAINST** | **ABSTAIN** | **BROKER** <br>**NON-VOTES** |
| Saumya Sutaria | 72297676 | 2036933 | 76905 | 5510667 |
| J. Robert Kerrey | 71837362 | 2539818 | 34334 | 5510667 |
| Vineeta Agarwala | 73763259 | 621321 | 26934 | 5510667 |
| James L. Bierman | 73793459 | 550313 | 67742 | 5510667 |
| Roy Blunt | 73768660 | 572299 | 70555 | 5510667 |
| Richard W. Fisher | 73759704 | 583669 | 68141 | 5510667 |
| Meghan M. FitzGerald | 73162461 | 1222005 | 27048 | 5510667 |
| Cecil D. Haney | 73782103 | 549561 | 79850 | 5510667 |
| Christopher S. Lynch | 73771835 | 570200 | 69479 | 5510667 |
| Richard J. Mark | 73767877 | 574980 | 68657 | 5510667 |
| Tammy Romo | 73149469 | 1233024 | 29021 | 5510667 |
| Nadja Y. West | 73659093 | 710537 | 41884 | 5510667 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;The Company's shareholders approved, on an advisory basis, the Company's executive compensation:

---

| | | | |
|:---|:---|:---|:---|
| **FOR** | **AGAINST** | **ABSTAIN** | **BROKER** <br>**NON-VOTES** |
| 62,554,346 | 11,817,273 | 39,895 | 5,510,667 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;The Company's shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
| **FOR** | **AGAINST** | **ABSTAIN** | **BROKER** <br>**NON-VOTES** |
| 79,422,386 | 470,477 | 29,318 |  |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | TENET HEALTHCARE CORPORATION |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date: May 29, 2026 | By: | /s/ THOMAS ARNST |
|  |  | Name: Thomas Arnst |
|  |  | Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary |

---